2022 American Transplant Congress
Infiltrating CD8+ Cytotoxic T Cells Are Converted to a Regulatory Phenotype in Accepted Kidney Allografts
*Purpose: Mouse kidney allografts are spontaneously accepted in select, fully-mismatched donor-recipient strain combinations (i.e. DBA/2J to C57BL/6 (B6)) without any immunosuppressive drug treatment. We have…2022 American Transplant Congress
Palliative Care for the Patients with Failing Kidney Allograft: Kraft Survey
*Purpose: Care of patients with failing kidney allograft can be challenging with discordant expectations between clinicians and patients. These patients often suffer from multiple morbidities,…2022 American Transplant Congress
Effect of Anti Thymocyte Globulin Induction Therapy in Kidney Transplantation Network Meta-Analysis Using Recent Data
Inha University, Incheon, Korea, Republic of
*Purpose: The use of induction immunosuppressant agents in transplantation is important factors in preserving graft kidney function to prevent rejection. However the question of which…2022 American Transplant Congress
Technical Report to Increased Utilization of Injured Kidneys: CT Scan to Evaluate Organ and Reduce Discard
Surgery, Columbia Vagelos College of Physicians and Surgeons, New York, NY
*Purpose: To reduce discard of injured kidneys with parenchymal injury or perinephric hematoma . Young donors with good function but injury are at high risk…2022 American Transplant Congress
Simultaneous Lung and Kidney Transplant in a Young Patient with COVID-19
*Purpose: Lung transplant is the last resort for COVID-19 refractory ARDS. Dual organ transplant is seen as a relative contraindication at many institutions. We describe…2022 American Transplant Congress
Ixazomib for Desensitization (IXADES): Results of a Phase II Clinical Trial
*Purpose: Ixazomib is a second-generation oral proteasome inhibitor, FDA approved for the treatment of refractory multiple myeloma. The purpose of the study was (1) to…2022 American Transplant Congress
Urinary Cell mRNA Profile Diagnosis of Borderline TCMR in Kidney Allografts
1Nephrology, Weill Cornell-NYPH, New York, NY, 2Pathology, Weill Cornell-NYPH, New York, NY
*Purpose: Borderline T cell-mediated rejection (BR) is associated with inferior outcomes. In the multicenter CTOT-04 study, we discovered and validated a urinary cell three-gene signature…2022 American Transplant Congress
Single Center Experience of Utilizing Genetic Testing (Renasight) in the Kidney Transplant Setting
KECK Medical Center at USC, Los Angeles, CA
*Purpose: Advances in next generation gene sequencing has made evaluation of genes associated with kidney easily accessible in the clinical settings. Renasight testing analyzes over…2022 American Transplant Congress
Predicting Urinary Tract Infections Requiring Hospitalization in Living Donor Kidney Transplant Recipients
*Purpose: Urinary tract infections (UTI) requiring hospitalization are common after kidney transplantation and are associated with increased risk of graft failure. Identifying patients at high…2022 American Transplant Congress
Twelve Month Outcomes of Kidney Transplantation from Hepatitis C Viremic Deceased Donors to Aviremic Recipients
Vanderbilt University Medical Center, Nashville, TN
*Purpose: The utilization of Hepatitis C viremic (HCV+) deceased donor kidneys for uninfected recipients allows for increased opportunities for organ transplantation. Initial studies have indicated…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 531
- Next Page »